Furthermore, at this time-point, detectable tumor-burden and malignant ascites were found only in 50% and 30% of animals treated with Ad-CD40L-DC respectively, whereas 100% of control animals already showed considerable tumor-mass and malignant ascites. This evidence concerns the gene CD40LG and neoplasm.